Loading…
Diversified Chinese conglomerate with holdings spanning pharma, insurance, tourism (Club Med) and consumer/retail brands.
Diversified Chinese conglomerate with holdings spanning pharma, insurance, tourism (Club Med) and consumer/retail brands.
Holds controlling stakes in operating businesses and books their results, so profit depends on a few big units such as the drugmaker Fosun Pharma, the Portuguese insurer Fidelidade and the resort operator Club Med. Since about 2020 it has sold assets to reduce debt and narrow its focus. Co-founder Guo Guangchang is chairman and the largest shareholder.
In one line: A Chinese Berkshire Hathaway-style conglomerate, more leveraged.
Moat: none (scale). A broad, leveraged holding company without a single dominant competitive position; value depends on subsidiary performance.
Headquarters: Shanghai, China · Founded: 1992 · Employees: 103,900
Size Fosun International (0656.HK) is a Hong Kong Consumer Discretionary company (Apparel/Footwear) with a market value of $4.82B, the 260th largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$4.67 on 6 Nov 2026.
Performance Over six months the shares gained 11.1%, against +4.4% for the median peer and -13.4% for the Hong Kong market (cap-weighted) — 7th highest of 21 in its peer set.
Growth Revenue fell 1.3% over the last twelve months (peer median +6.5%); the operating margin is 3.0% (peer median 13.3%).
Valuation It trades at 12.9× forward earnings against a peer median of 14.4× (7th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 4.1 points below its cost of capital (5.2% WACC).
Next results Next results expected around 31 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | HK$193B | HK$188B | HK$208B | HK$219B | HK$212B |
| Revenue growth | — | -10% | -5% | +3% | — |
| Gross profit | HK$54.5B | HK$51.9B | HK$55.9B | HK$56.1B | HK$55.0B |
| EBITDA | HK$18.9B | HK$16.3B | HK$18.1B | HK$13.3B | HK$14.8B |
| Net income | -HK$24.4B | -HK$25.4B | -HK$4.72B | HK$1.52B | -HK$967M |
| Free cash flow | HK$21.9B | HK$16.8B | HK$16.1B | -HK$9.01B | -HK$2.26B |
| Capital expenditure | HK$13.4B | HK$12.3B | HK$12.4B | HK$15.0B | HK$14.3B |
| Total debt | n/a | HK$281B | HK$259B | HK$261B | HK$279B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Fosun International 0656.HK | $4.82B | +11% | -1% | 3% | 12.9× | 10.6% |
| Ckh 0001.HK | $34.3B | -2% | -2% | 11% | 11.3× | 1.2% |
| Legend 3396.HK | $4.03B | +34% | +27% | 4% | 4.8× | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 0656.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -4.0% | +12.5% | 3rd lowest of 21 |
| 6-month return | +11.1% | +4.4% | 7th highest of 21 |
| Distance from 52-week high | -17.6% | -12.2% | 7th lowest of 21 |
| Revenue growth (TTM) | -1.3% | +6.5% | 5th lowest of 21 |
| Operating margin | 3.0% | 13.3% | 3rd lowest of 21 |
| Forward P/E | 12.9× | 14.4× | 7th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | 10.6% | 4.6% | 8th most demanding of 20 |
| Growth delivered (Del g) | +4.1% | +12.4% | 4th lowest of 20 |
| Hurdle (Req g minus delivered) | +6.5 pp | -7.2 pp | 6th most demanding of 20 |
| ROIC minus cost of capital | -4.1 pp | +9.0 pp | 4th lowest of 21 |
| EV / EBITDA | 13.4× | 10.8× | 6th most expensive of 17 |
| Net debt / EBITDA | 6.6× | 1.1× | most indebted of 17 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Fosun International 0656.HK | Hong Kong | $4.82B | +11% | -1% | 3% | 12.9× | 10.6% | +4.1% |
| Abc-mart 2670.T | Japan | $5.03B | +20% | +4% | 17% | 16.2× | -10.0% | +11.4% |
| Li Ning 2331.HK | Hong Kong | $5.10B | -21% | +7% | 13% | 14.4× | -5.4% | +14.6% |
| HLA 600398.SS | China | $4.47B | -6% | +7% | 11% | 14.3× | -13.1% | +3.8% |
| Puma PUM.DE | Germany | $4.42B | +4% | -19% | -6% | n/a | n/a | n/a |
| Burberry BRBY.L | United Kingdom | $5.38B | -4% | -2% | 7% | 28.8× | 19.1% | +0.6% |
| Page Industries PAGEIND.NS | India | $4.22B | -4% | +8% | 19% | 46.8× | 27.7% | +13.1% |
| Kontoor Brands KTB | United States | $4.21B | +5% | +16% | 13% | 13.2× | 1.1% | +8.5% |
| K.P.R. Mill KPRMILL.NS | India | $4.21B | +19% | +6% | 18% | 34.8× | 29.9% | +13.3% |
| PVH PVH | United States | $4.15B | +1% | +2% | 8% | 8.1× | 2.5% | +4.6% |
| Youngor Fashion 600177.SS | China | $5.69B | +10% | -5% | -3% | 12.8× | 23.3% | +0.1% |
| Ermenegildo Zegna ZGN | United States | $5.96B | +7% | +11% | 9% | 31.1× | 20.3% | +11.3% |
| Columbia Sportswear COLM | United States | $3.61B | +12% | 0% | 8% | 16.2× | 4.6% | +6.3% |
| Gildan Activewear GIL.TO | Canada | $6.48B | -40% | +40% | 15% | 6.8× | 6.5% | +13.7% |
| Brunello Cucinelli BC.MI | Italy | $6.61B | +4% | +10% | 18% | 37.8× | 20.6% | +20.9% |
| Birkenstock BIRK | United States | $6.64B | -5% | +20% | 24% | 13.9× | 7.4% | +19.9% |
| Bosideng International 3998.HK | Hong Kong | $6.64B | +3% | +8% | 18% | 10.3× | -10.8% | +14.2% |
| Crocs CROX | United States | $6.94B | +47% | +1% | 23% | 9.6× | 1.1% | +23.9% |
| FIGS FIGS | United States | $3.29B | +37% | +25% | 10% | 54.0× | 25.5% | +19.1% |
| Huali Industrial 300979.SZ | China | $7.09B | +6% | -10% | 14% | 19.7× | -4.4% | +12.4% |
| Crystal International 2232.HK | Hong Kong | $2.92B | +23% | +4% | 10% | 11.4× | -5.3% | +6.0% |